Trial Profile
A clinical study of the Human Fibrin Sealant product
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 15 Jun 2018
Price :
$35
*
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Surgical blood loss
- Focus Adverse reactions
- 15 Jun 2018 New trial record
- 11 Jun 2018 According to a China Biologic Products media release, this study may expects to initiate in 2018 and at least one year to complete the trial.